Research Topics
Genomes and GenesSpecies | David B SeiferSummaryAffiliation: Maimonides Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cyclesDavid B Seifer
Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
Fertil Steril 77:468-71. 2002....
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significanceDavid B Seifer
Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York 11228, USA
Fertil Steril 88:539-46. 2007..To examine Mullerian Inhibiting Substance (MIS) as an emerging diagnostic marker of ovarian function...
Strategic planning is long overdue and could mitigate long-term complications that result from delayed diagnosis of primary ovarian insufficiencyDavid B Seifer
Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, Brooklyn, New York, USA
Fertil Steril 95:1898; discussion 1902. 2011..Timely diagnosis with less delay results in less morbidity and ultimately greater patient satisfaction with the quality of received medical care...
Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in womenDavid B Seifer
Maimonides Medical Center, Department of Obstetrics and Gynecology, Brooklyn, New York, USA
Fertil Steril 88:1645-52. 2007..To determine whether HIV infection influences early follicular MIS levels, an early marker of ovarian aging...
Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United StatesDavid B Seifer
Maimonides Medical Center, Department of Obstetrics and Gynecology, Genesis Fertility and Reproductive Medicine, Brooklyn, New York, USA
Fertil Steril 95:747-50. 2011..To determine age-specific serum anti-Müllerian hormone (AMH) values for women presenting to U.S. fertility clinics...
Trends of racial disparities in assisted reproductive technology outcomes in black women compared with white women: Society for Assisted Reproductive Technology 1999 and 2000 vs. 2004-2006David B Seifer
Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, 1355 84th Street, Brooklyn, NY 11228, USA
Fertil Steril 93:626-35. 2010..To determine trends in assisted reproductive technology (ART) in black and white women by comparing Society for Assisted Reproductive Technology (SART) database outcomes for 2004-2006 with previously reported outcomes for 1999 and 2000...
Disparity in assisted reproductive technologies outcomes in black women compared with white womenDavid B Seifer
Genesis Fertility and Reproductive Medicine, Maimonides Medical Center, Brooklyn, New York 11228, USA
Fertil Steril 90:1701-10. 2008..To compare success rates in black and white women undergoing IVF...
Variations in serum müllerian inhibiting substance between white, black, and Hispanic womenDavid B Seifer
Department of Obstetrics and Gynecology, Brooklyn, and Mount Sinai School of Medicine, Maimonides Medical Center, New York, New York 11228, USA
Fertil Steril 92:1674-8. 2009..To compare serum müllerian inhibiting substance (MIS) levels between white, black, and Hispanic women to determine whether ovarian aging occurs at a different time course for women of different racial groups...
Plasma brain-derived neurotrophic factor in women after bariatric surgery: a pilot studyZaher O Merhi
Maimonides Medical Center, Brooklyn, New York, USA
Fertil Steril 91:1544-8. 2009..Brain-derived neurotrophic factor decreased significantly in all the participants and in the premenopausal group when looked at in isolation...
Relationship of bariatric surgery to Müllerian-inhibiting substance levelsZaher O Merhi
Maimonides Medical Center, 967 48th Street, Brooklyn, New York 11219, USA
Fertil Steril 90:221-4. 2008
Serum müllerian-inhibiting substance in Down's syndrome pregnanciesDavid B Seifer
Maimonides Medical Center, Brooklyn, New York, NY, USA
Hum Reprod 22:1017-20. 2007..To examine whether maternal serum levels of müllerian-inhibiting substance (MIS) differ in Down's syndrome and unaffected pregnancies...
Follicular-fluid neurotrophin levels in women undergoing assisted reproductive technology for different etiologies of infertilityErkan Buyuk
Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York, USA
Fertil Steril 90:1611-5. 2008..To determine follicular-fluid neurotrophin levels in women undergoing assisted reproductive techniques for different etiologies of infertility...
Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal womenMuhammad Faisal Aslam
Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York 11219, USA
Fertil Steril 95:1790-3. 2011..Unlike MIS, BDNF levels were not reduced after chemotherapy...
Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandatesSamantha F Butts
Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Electronic address
Fertil Steril 99:382-388.e7. 2013....
Comparison of serum and plasma measurements of Müllerian inhibiting substanceZaher O Merhi
Maimonides Medical Center, Brooklyn, New York 11219, USA
Fertil Steril 89:1836-7. 2008..Levels of MIS were measured with an ELISA kit, and plasma levels were studied in parallel to serum samples. A 98.5% correlation was found between serum and plasma MIS values...
Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatmentRichard Fleming
University Department of Obstetrics and Gynaecology, Royal Infirmary, Glasgow, United Kingdom
Fertil Steril 83:130-6. 2005..Assessment of ovarian responses to metformin treatment in obese women with polycystic ovary syndrome (PCOS)...
Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiolAndré Hazout
ART Unit Eylau la Muette, Clinic La Muette, Paris, France
Fertil Steril 82:1323-9. 2004..To test the hypothesis that the concentration of early follicular phase serum antimullerian hormone (AMH) or mullerian-inhibiting substance (MIS) is a useful marker of ovarian response and assisted reproductive technology (ART) outcome...
Practice patterns among board-certified reproductive endocrinologists regarding high-order multiple gestations: a united states national surveyDoreen L Hock
Reproductive Medicine Associates of New Jersey, Somerset, USA
Obstet Gynecol 99:763-70. 2002..Given the inconsistent practice patterns, a multifaceted educational approach may provide an opportunity to reduce the incidence of high-order multiple gestations and their sequelae...
DNA microarray analysis of the expression profiles of luteinized granulosa cells as a function of ovarian reserveKhew Voon Chin
The Cancer Institute of New Jersey, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
Fertil Steril 77:1214-8. 2002..To examine the expression profiles of luteinized granulosa cells isolated from women with normal or diminished ovarian reserve undergoing in vitro fertilization...
Mitochondrial deletions in luteinized granulosa cells as a function of age in women undergoing in vitro fertilizationDavid B Seifer
Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
Fertil Steril 78:1046-8. 2002..To test the hypothesis that mitochondrial DNA (mtDNA) deletions are more prevalent in granulosa cells from women of advanced reproductive age than from younger women undergoing IVF...
Ovarian brain-derived neurotrophic factor is present in follicular fluid from normally cycling womenDavid B Seifer
Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
Fertil Steril 79:451-2. 2003
Impact of retained embryos on the outcome of assisted reproductive technologiesHye-Chun Lee
Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Reproductive Endocrinology and Infertility, UMDNJ-Robert Wood Johnson Medical School, 303 George Street, New Brunswick, NJ 08901, USA
Fertil Steril 82:334-7. 2004..CONCLUSION(S): Immediate retransfer of embryos retained in the catheter following the initial transfer attempt did not have an adverse effect on pregnancy outcome...
Immunocytochemical evidence for the presence and location of the neurotrophin-Trk receptor family in adult human preovulatory ovarian folliclesDavid B Seifer
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ, USA
Am J Obstet Gynecol 194:1129-34; discussion 1134-6. 2006..This study was undertaken to evaluate the presence or absence of neurotrophins and their respective receptors within adult human preovulatory follicles...
Effects of HIV infection and its treatment on self-reported menstrual abnormalities in womenL Stewart Massad
Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
J Womens Health (Larchmt) 15:591-8. 2006..To describe menstrual abnormalities among women with HIV...
Social concerns of women undergoing infertility treatmentPeter S Finamore
Department of Obstetrics, Gynecology and Reproductive Sciences, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
Fertil Steril 88:817-21. 2007..We hypothesize that, in certain women, disclosure may lower stress, and therefore increase success rate of in vitro fertilization...
Research Grants
- BIOLOGICAL BASIS OF THE PERIMENOPAUSEDAVID SEIFER; Fiscal Year: 2002....
